| __timestamp | Soleno Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 1802274 |
| Thursday, January 1, 2015 | 7878291 | 2512761 |
| Friday, January 1, 2016 | 8366794 | 2894488 |
| Sunday, January 1, 2017 | 6610381 | 8096274 |
| Monday, January 1, 2018 | 6556000 | 7985229 |
| Tuesday, January 1, 2019 | 6930000 | 8994597 |
| Wednesday, January 1, 2020 | 8758000 | 29772000 |
| Friday, January 1, 2021 | 10806000 | 33907000 |
| Saturday, January 1, 2022 | 9844000 | 26579000 |
| Sunday, January 1, 2023 | 13481000 | 49868547 |
In pursuit of knowledge
In the competitive world of biopharmaceuticals, effective cost management is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Soleno Therapeutics, Inc. over the past decade. From 2014 to 2023, Verona Pharma's SG&A expenses surged by over 2,600%, peaking at nearly $50 million in 2023. This dramatic increase reflects the company's aggressive expansion and investment in its operational infrastructure. In contrast, Soleno Therapeutics exhibited a more modest growth of approximately 360% in the same period, with expenses reaching around $13 million in 2023. This steady rise suggests a more conservative approach to scaling operations. Understanding these trends provides valuable insights into each company's strategic priorities and financial health, offering a window into their future trajectories in the biopharma landscape.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Verona Pharma plc
Who Optimizes SG&A Costs Better? AbbVie Inc. or Verona Pharma plc
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Novartis AG and Verona Pharma plc
Summit Therapeutics Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Verona Pharma plc and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Verona Pharma plc vs MiMedx Group, Inc. Trends and Insights
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Merus N.V. vs Soleno Therapeutics, Inc.: SG&A Expense Trends